SB 190

An Act providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; establishing the Pharmaceutical Transparency Review Fund; and imposing a penalty.

In committee Last action January 29, 2025: Referred to Banking & Insurance

Official bill page and text: palegis.us

Sponsors 8

Prime sponsor: Sharif Street
Cosponsors (7): Daniel Laughlin, Jay Costa, John Kane, Judith Schwank, Maria Collett, Timothy Kearney, Vincent Hughes

Status

In committee as of January 29, 2025. Session ends November 30, 2026; the 2027–2028 session begins in January 2027.

Roll-call votes 0

No roll-call votes recorded for this measure.

Timeline 1

Date	Chamber	Action
January 29, 2025	Senate	Referred to Banking & Insurance

Data: Open States (API v3; public data, attribution appreciated), updated November 5, 2026. Official record: palegis.us. Bill pages link to the official text, not copied.

Sources for this page

Open States API v3 (Plural Policy): https://v3.openstates.org/ — copied November 2, 2026

Pennsylvania General Assembly: https://www.palegis.us/legislation/bills — copied November 2, 2026

Bill, action and roll-call data from Open States (public data, attribution appreciated). Neither Pennsylvania Capitol Guide nor this information, as presented here, is endorsed by the Pennsylvania General Assembly.